Latest article

Redefining Early Detection in Neurodegenerative Care For years, confirming Alzheimer’s pathology required navigating two extremes: invasive lumbar punctures or scarce, cost-prohibitive PET imaging. Consequently, clinical diagnosis frequently arrived too late—well after significant...

Next-Gen Alzheimer’s Biomarker Profiling: Human Beta-Amyloid 1-40 & 1-42 Detection Kit (Digital Immunochip Method) Alzheimer’s disease (AD) pathology initiates decades prior to the overt onset of memory loss and cognitive decline. Pathophysiologically...

I. Accelerating the Transition to Digital Pathology Modern healthcare demands faster turnaround times, consistent diagnostic precision, and borderless clinical collaboration. Conventional microscopy, while foundational, creates workflow bottlenecks—vulnerable glass slides, manual archiving challenges,...

To: Our Valued Clients, Strategic Partners, and All Employees, On the occasion of Vietnam National Day (September 2nd, 2026), DOIT SCIENTIFIC JSC respectfully announces our upcoming holiday schedule to facilitate your work...

DOIT Scientific JSC reinforces its biotechnology leadership through the comprehensive transfer and operational deployment of an advanced NGS system for clinical and diagnostic partners. Delivering Next-Generation Genomic Solutions DOIT Scientific JSC has...

DOIT Scientific makes a powerful impression at the 24th Vietnam Medipharm Expo 2026 with its breakthrough blood-based Alzheimer’s early detection solution, paving the way for strategic healthcare partnerships. 1. Highlights from the...